These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35525524)

  • 1. Noncontrast T1ρ dispersion imaging is sensitive to diffuse fibrosis: A cardiovascular magnetic resonance study at 3T in hypertrophic cardiomyopathy.
    Wang K; Zhang W; Li S; Jin H; Jin Y; Wang L; Li R; Yang Y; Zheng J; Cheng J
    Magn Reson Imaging; 2022 Sep; 91():1-8. PubMed ID: 35525524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Thompson EW; Kamesh Iyer S; Solomon MP; Li Z; Zhang Q; Piechnik S; Werys K; Swago S; Moon BF; Rodgers ZB; Hall A; Kumar R; Reza N; Kim J; Jamil A; Desjardins B; Litt H; Owens A; Witschey WRT; Han Y
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):120. PubMed ID: 34689798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.
    Ando K; Nagao M; Watanabe E; Sakai A; Suzuki A; Nakao R; Ishizaki U; Sakai S; Hagiwara N
    Eur Radiol; 2020 Aug; 30(8):4327-4336. PubMed ID: 32211964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
    Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous assessment of late gadolinium enhancement grey zone in patients with non-ischaemic cardiomyopathy with T1ρ and native T1 mapping.
    Dong Z; Yin G; Yang K; Jiang K; Wu Z; Chen X; Song Y; Yu S; Wang J; Yang S; Ma X; Xu Y; Zhao K; Lu M; Xu X; Zhao S
    Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):492-502. PubMed ID: 35793269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.
    Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J
    Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR extracellular volume mapping and non-contrast T1ρ mapping allow early detection of myocardial fibrosis in diabetic monkeys.
    Zhang Y; Zeng W; Chen W; Chen Y; Zhu T; Sun J; Liang Z; Cheng W; Wang L; Wu B; Gong L; Ferrari VA; Zheng J; Gao F
    Eur Radiol; 2019 Jun; 29(6):3006-3016. PubMed ID: 30643944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
    Dass S; Suttie JJ; Piechnik SK; Ferreira VM; Holloway CJ; Banerjee R; Mahmod M; Cochlin L; Karamitsos TD; Robson MD; Watkins H; Neubauer S
    Circ Cardiovasc Imaging; 2012 Nov; 5(6):726-33. PubMed ID: 23071146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
    Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
    J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endogenous T1ρ and its dispersion imaging in differential diagnosis of cardiac amyloidosis.
    Wang K; Zhang Y; Zhang W; Jin H; An J; Cheng J; Zheng J
    J Cardiovasc Magn Reson; 2024 Aug; 26(2):101080. PubMed ID: 39127261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of myocardial magnetic resonance extracellular volume mapping at 3 T against histology of tissue collagen in severe aortic valve stenosis and obstructive hypertrophic cardiomyopathy.
    Bakermans AJ; Kouwenhoven M; de Vos J; de Vries DK; Reckman YJ; Farag ES; Koolbergen DR; Kluin J; Nederveen AJ; Strijkers GJ; Boekholdt SM
    MAGMA; 2023 Oct; 36(5):701-709. PubMed ID: 36820958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.
    Brouwer WP; Baars EN; Germans T; de Boer K; Beek AM; van der Velden J; van Rossum AC; Hofman MB
    J Cardiovasc Magn Reson; 2014 Apr; 16(1):28. PubMed ID: 24766828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
    Al-Wakeel-Marquard N; Seidel F; Herbst C; Kühnisch J; Kuehne T; Berger F; Klaassen S; Messroghli DR
    Int J Cardiol; 2021 Jun; 333():219-225. PubMed ID: 33737165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
    Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
    J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance.
    Nguyen C; Lu M; Fan Z; Bi X; Kellman P; Zhao S; Li D
    J Cardiovasc Magn Reson; 2015 Dec; 17():107. PubMed ID: 26631061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
    Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
    Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y
    Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.